Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer

NCT07717099 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Hormone-Sensitive Prostate Cance

Interventions

DRUG: Ra223
DRUG: Darolutamide Oral Tablet
OTHER: Androgen Deprivation Therapy (ADT)

Sponsor

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Collaborators

[object Object]
[object Object]